You are here: Industry Insights > India

News List

E-pharma set to revolutionise drug market access in India: GlobalData expresspharma
September 17, 2020
E-pharma companies will offer competitive pricing and access to quality medicines even in remote places along with the ease of consultation.
Patient activist groups express relief over pause of Covishield trials in India expresspharma
September 14, 2020
They call for more timely responses and accountability on part of both regulators and companies to ensure patient safety.
Six reasons why India is poised to be a global leader in nutraceuticals expresspharma
September 03, 2020
An overview of India Nutra Inc’s comparative advantages, growth drivers and development potential.
India’s proposed new agile pharma regulations will benefit innovator companies: GlobalData expresspharma
August 28, 2020
This could mean accelerated access of multiple novel therapies and vaccines for Indian patients.
Govt may set up ‘Mission COVID Suraksha’ with Rs 3000 crore corpus expresspharma
August 26, 2020
The initiative will work towards fast-tracking development and manufacture of COVID-19 vaccines in the country.
Govt may consider amendments in PLI scheme, submit recommendations: Dr Eswara Reddy expresspharma
August 26, 2020
Dr Eswara Reddy, Joint Drug Controller General of India has asked industry associations to make the representations on the amendments required in the recently released detailed production linked incentive (PLI) scheme.
Industry urges DoP to expedite implementation of PTUAS expresspharma
August 25, 2020
The pharma industry raised the issues related to the implementation process of Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS) scheme, in a recently held DoP meeting with industry stakeholders.
India gives nod to cell therapy for Critical Limb Ischemia (CLI) europeanpharmaceuticalreview
August 25, 2020
Stempeucel®, a cell therapy for the treatment of Critical Limb Ischemia (CLI), has been approved for commercial use in India by the Drug Controller General.
Dr Reddy’s Laboratories launches AVIGAN (favipiravir) in India expresspharma
August 20, 2020
Dr Reddy’s Laboratories announced the launch of AVIGAN (favipiravir) 200 mg tablets in India.
D&C Act 1940 should be reframed: Pharma stakeholders expresspharma
August 19, 2020
Pharma industry stakeholders feel that the Drugs and Cosmetics Act needs to be reframed to streamline drug regulatory affairs in India.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 33 34 Next page